We found that the expression of UBL3 was significantly higher in non-smoking than in smoking patients and that non-smoking patients with NSCLC with high levels of UBL3 had much more favorable prognosis than those who smoked (Figure 3). Here, UBL3 is linked to non-small cell lung carcinoma.